Bio-Rad Laboratories Inc, Hercules, Calif, and Inpeco, Lugano, Switzerland, have entered into a development agreement to build interfaces between Bio-Rad’s clinical diagnostics platforms for diabetes, autoimmune disease, and infectious disease testing, and Inpeco’s FlexLab system.
Connecting Bio-Rad instruments to the Inpeco FlexLab system offers clinical diagnostics labs a complete and integrated solution that automates sample processing, consolidates testing platforms, and improves operating efficiency of the instruments.
With increasing test volumes and the demand for faster turnaround times, many labs are implementing total laboratory automation solutions. Automated track systems prepare, sort, and transport patient samples between instruments, eliminating the need for manual intervention.
The first Bio-Rad systems to be interfaced to the FlexLab system are the VARIANT™ II TURBO hemoglobin testing system (pictured) and the BioPlex® 2200 system.
The VARIANT II TURBO system is a fully-automated system that uses high-performance liquid chromatography (HPLC) to deliver fast and precise measurement of hemoglobin A1C, which is used to monitor average blood glucose levels over time in patients with diabetes. The BioPlex 2200 system uses proprietary multiplex chemistry to deliver full automation and random-access testing for autoimmune diseases and infectious diseases.
[Source: Bio-Rad]
 |
 |
 |
 |
CLP is the only magazine that focuses exclusively on products and technology for the clinical lab industry. Every month, CLP's editorial provides 45,000 pathologists, lab managers, administrators and technologists with comprehensive coverage of new products and technology.
RSS